PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1477915
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1477915
Newborn Screening Market - By Product Type (Instruments, Consumables), Technology (Tandem Mass Spectrometry, Oximetry, Enzyme-Based Assays, DNA Assays), Test Type (Dried Blood Spot, Hearing Screening, CCHD), End-use - Global Forecast, 2024 - 2032
Global Newborn Screening Market Size will grow at 7.7% CAGR during 2024-2032, driven by increasing government initiatives for early disease detection, growing awareness among healthcare professionals and parents, and rising demand for high-quality consumables in newborn screening tests.
According to WHO, as neonatal and under-5 mortality rates decrease, congenital disorders represent a growing proportion of these deaths. With an increasing number of infants being born with congenital conditions globally, there's a pressing need for early detection and intervention to mitigate the potential impact on their health and well-being.
These disorders encompass a wide spectrum, ranging from metabolic disorders to congenital heart defects, spinal muscular atrophy, and various genetic abnormalities. As awareness grows regarding the significance of early diagnosis in improving clinical outcomes and reducing healthcare costs, healthcare systems are investing more resources into newborn screening programs, resulting in a surge in demand for screening tests and related services.
The Newborn Screening Market is classified based on product type, technology, test type, end-use, and region.
Consumables segment will grow substantially between 2024 and 2032, owing to their pivotal role in the newborn screening process, encompassing a range of products such as blood collection devices, reagents, and assay kits. With the increasing volume of newborn screening tests conducted globally, there is a growing demand for high-quality consumables to ensure accurate and reliable results. Manufacturers in the newborn screening market are focusing on developing innovative consumables that enhance testing efficiency while maintaining stringent quality standards. Furthermore, the advent of dried blood spot (DBS) technology has simplified sample collection and transportation, thereby inducing segment growth.
The Newborn Screening Market Share from the oximetry segment will garner noticeable gains through 2032, as pulse oximeters are commonly used to screen for congenital heart defects and other respiratory conditions in newborns, enabling early detection and timely intervention. The integration of oximetry into newborn screening protocols has improved the detection rate of critical congenital heart diseases (CCHD), leading to better clinical outcomes and reduced healthcare costs. Moreover, as healthcare facilities upgrade their screening infrastructure, further segment growth is anticipated.
Asia Pacific Newborn Screening Industry will exhibit a decent growth rate through 2032, driven by the increasing emphasis on preventive healthcare and the growing prevalence of genetic disorders in the region. Countries such as China, India, and Japan are witnessing a surge in government initiatives aimed at expanding newborn screening programs and improving healthcare infrastructure. Moreover, rising healthcare expenditure and greater awareness among parents regarding the importance of early disease detection are fueling market growth in the region.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing incidence of genetic and metabolic disorders
- 3.2.1.2 Advancements in technology
- 3.2.1.3 Rising awareness among healthcare professionals and parents
- 3.2.1.4 Rising birth rates and population growth
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Lack of uniformity of newborn screening procedure around the world
- 3.2.2.2 Stringent regulatory polices
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technological landscape
- 3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Instruments
- 5.2.1 Dried blood spot puncher
- 5.2.2 Hearing screening devices
- 5.2.3 Analyzers
- 5.2.4 Electrophoresis unit
- 5.2.5 Pulse oximetry
- 5.2.6 Other instruments
- 5.3 Consumables
Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Tandem mass spectrometry
- 6.3 Oximetry
- 6.4 Enzyme-based assays
- 6.5 DNA assays
- 6.6 Other technologies
Chapter 7 Market Estimates and Forecast, By Test Type, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Dried blood spot
- 7.3 Hearing screening
- 7.4 Critical congenital heart defect (CCHD)
- 7.5 Other test types
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Hospitals
- 8.3 Diagnostic centers
- 8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Agilent Technologies, Inc.
- 10.2 Bio-Rad Laboratories, Inc.
- 10.3 GE Healthcare
- 10.4 Masimo Corporation
- 10.5 Medtronic plc
- 10.6 Natus Medical Incorporated
- 10.7 PerkinElmer, Inc.
- 10.8 Thermo Fisher Scientific Inc.
- 10.9 Trivitron Healthcare
- 10.10 Waters Corporation
